the majority of therapeutic trials in asthma have been of short term duration and have demonstrated that conventional doses of inhaled budesonide ( 200 to 800 micrograms/day ) and beclomethasone dipropionate ( 400 to 800 micrograms/day ) are of similar efficacy in both adults and children with moderate to severe asthma .
C0004096
asthma
C0004906
beclomethasone dipropionate